H.R. 1796 · 119th Congress (2025–2027)
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
This bill reauthorizes through FY2029 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve prevention and treatment of sickle cell disease and complications from the disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)
Show official title
To amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 1796’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. John James (R-MI-10)
- Cosponsors
6 cosponsors
4 original · 2 later
1 R · 5 D
- Rep. Troy A. Carter (D-LA-2)· Original · Mar 3, 2025
- Rep. Danny K. Davis (D-IL-7)· Original · Mar 3, 2025
- Rep. Jennifer A. Kiggans (R-VA-2)· Original · Mar 3, 2025
- Rep. Marc A. Veasey (D-TX-33)· Original · Mar 3, 2025
- Rep. Eugene Simon Vindman (D-VA-7)· Later · Aug 15, 2025
- Rep. Sanford D. Bishop, Jr. (D-GA-2)· Later · Jan 16, 2026
- Policy area
- Health
- Subjects
- Blood and blood diseases
- Genetics
- Health promotion and preventive care
- Hereditary and development disorders
- Medical research
- Research administration and funding
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Display title, Short title · Introduced in House
To amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program.
Official title · Introduced in House